Ascendis Pharma A/S (ASND) has a market capitalization of $15.34B and trades at $249.84. The 52-week range is 124.06-248.6.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -69, Earnings Per Share (EPS) of $-3.62, annual revenue of $691.71M.
The stock has a beta of 0.49, operates in the Healthcare sector.
